Work

Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of Affective Disorders

DOI: 10.1016/j.jad.2018.10.289

Authors: Maggie Fedgchin, Madhukar Trivedi, Ella J. Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael Liebowitz, Arun Ravindran, Raphael Gaillard, Hans van den Ameele, Husseini Manjii, David Hough, Wayne C. Drevets, Jaskaran B. Singh

Institutions: Janssen (United States), Janssen Research & Development (United States), The University of Texas Southwestern Medical Center, University of Ottawa, Institute of Mental Health Research, Massachusetts General Hospital, Medical Research Network, Centre for Addiction and Mental Health, University of Toronto, Campbell Family Mental Health Research Institute, Centre Hospitalier Sainte-Anne, AZ Sint-Jan

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2953974969

FWCI: 0.653

Cites:

Cited by: 5

Related to: 10